Assembly Biosciences (ASMB) EPS (Diluted) Growth (1y) (2019 - 2026)
Powered by 
Analysis
Assembly Biosciences (ASMB) EPS (Diluted) Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 8.02% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -4.52% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 89.89% |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 7.59% |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 144.25% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 315.14% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -11.18% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 96.41% |
| 10 | Assembly Biosciences | 687.78 Mn | 367.42 Mn | - | 84.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84.64% |
| Mar 31, 2026 | 54.27% |
| Dec 31, 2025 | 221.14% |
| Sep 30, 2025 | 52.11% |
| Jun 30, 2025 | 32.60% |
| Mar 31, 2025 | 29.04% |
| Dec 31, 2024 | 28.13% |
| Sep 30, 2024 | 54.02% |
| Jun 30, 2024 | 49.06% |
| Mar 31, 2024 | 62.87% |
| Dec 31, 2023 | 54.81% |
| Sep 30, 2023 | 42.58% |
| Jun 30, 2023 | 36.17% |
| Mar 31, 2023 | 24.41% |
| Dec 31, 2022 | 69.56% |
| Sep 30, 2022 | -15.78% |
| Jun 30, 2022 | 7.96% |
| Mar 31, 2022 | 32.62% |
| Dec 31, 2021 | -37.25% |
| Sep 30, 2021 | -359.46% |